1. Academic Validation
  2. LINC01588 regulates WWP2-mediated cardiomyocyte injury by interacting with HNRNPL

LINC01588 regulates WWP2-mediated cardiomyocyte injury by interacting with HNRNPL

  • Environ Toxicol. 2022 Jul;37(7):1629-1641. doi: 10.1002/tox.23512.
Yanbin Song 1 2 Xiaoyue Ren 3 Feng Gao 1 2 Fei Li 1 2 Jing Zhou 1 2 Junmin Chen 1 2 Yunqing Zhang 4
Affiliations

Affiliations

  • 1 Department of Cardiovasology, Yan'an University Affiliated Hospital, China.
  • 2 Heart and Brain Laboratory, Yan'an University Affiliated Hospital, China.
  • 3 Department of Oncology, Yan'an University Affiliated Hospital, China.
  • 4 Department of Pathology, Yan'an University Affiliated Hospital, China.
Abstract

Cardiomyocyte dysfunction and Apoptosis induced by ischemia-hypoxia are common features of many acute and chronic heart diseases. WW domain-containing E3 ubiquitin Ligase (WWP2) has been identified as an important regulator in pathogenesis of some health-threatening diseases. Although a couple of recent reports prompted the potential role of WWP2 in heart dysfunction, however, its exact role and how its expression was regulated in ischemic-hypoxic cardiomyocytes are still elusive. Here, we found that WWP2 protein level was induced in anoxia/reoxygenation (A/R) treated cardiomyocytes in a time-dependent manner, accompanied by synchronous expression of LINC01588 and HNRNPL. Knockdown of LINC01588 increased cardiomyocyte Apoptosis, the level of oxidative stress, and expression of pro-inflammatory cytokine genes, down-regulated the expression of WWP2 and promoted expression of SEPT4 gene that contributed to cardiomyocyte dysfunction and was a target gene of WWP2. LINC01588 overexpression improved the functions of A/R treated cardiomyocytes, up-regulated WWP2 and reduced SEPT4 expression. In the mechanism exploration, we found that LINC01588 could directly bind with HNRNPL protein that could interact with WWP2, suggesting that WWP2 was involved in the regulation of LINC01588 in A/R treated cardiomyocytes. Moreover, WWP2 inhibition declined the protective role of LINC01588 in cardiomyocyte dysfunction induced by A/R. Finally, we demonstrated that LINC01588 overexpression improved acute myocardial infarction in mice in vivo. In conclusion, LINC01588 improved A/R-induced cardiomyocyte dysfunction by interacting with HNRNPL and promoting WWP2-mediated degradation of SEPT4.

Keywords

HNRNPL; LINC01588; SEPT4; WWP2; ischemia/reperfusion injury.

Figures
Products